When researchers encounter the abbreviations HPLC and LC-MS on a Certificate of Analysis, they are looking at the results of the two most important analytical methods for verifying a synthetic peptide's quality. Together, these techniques answer the two fundamental questions any researcher must answer before working with a sourced compound: how pure is it? and is it actually what it claims to be?
This entry explains both techniques in plain terms — what they measure, how they work, what the numbers mean, and critically, why neither method alone is sufficient.
High-Performance Liquid Chromatography (HPLC)
What HPLC Measures
HPLC separates the chemical components of a dissolved sample by passing it through a column packed with stationary phase material. Different compounds interact with the stationary phase to different degrees and therefore travel through the column at different rates. The detector — typically a UV/Vis detector for peptides — records the abundance of each component as it exits the column, producing a chromatogram.
Purity is calculated as the percentage of total peak area attributable to the main compound peak. A result of 98.5% means 98.5% of the detected signal corresponds to the target compound; the remaining 1.5% represents impurities — which may include synthesis by-products, truncated sequences, oxidised residues, or other co-eluting compounds.
Interpreting HPLC Purity Results
The ≥98% threshold is the research-grade standard because it represents the point at which the target compound constitutes the dominant and highly predominant component of the sample. Below this level, the impurity fraction is significant enough to introduce material variables into any research application.
It is important to understand that HPLC does not identify compounds — it only separates and quantifies them. A sample at 99.2% HPLC purity tells you that 99.2% of the detected signal comes from a single dominant compound. It does not tell you which compound that is. This is the fundamental limitation that LC-MS addresses.
What HPLC Cannot Tell You
- The identity of the dominant compound — a different peptide of similar size could show identical HPLC purity
- The presence of compounds that are transparent at the detection wavelength
- Microbiological contamination or endotoxin presence
- Degradation compounds that co-elute with the main peak
Liquid Chromatography–Mass Spectrometry (LC-MS)
What LC-MS Measures
LC-MS combines liquid chromatographic separation with mass spectrometric detection. After separating the sample components by LC, the mass spectrometer measures the mass-to-charge ratio (m/z) of the ionised compounds. For peptides, electrospray ionisation (ESI) is the most common ionisation method, producing multiply charged ions whose masses can be mathematically deconvoluted to yield the true molecular weight of the compound.
Identity confirmation is achieved by comparing the observed molecular weight against the theoretical molecular weight calculated from the compound's amino acid sequence. A match within instrument tolerance (typically ±0.02 Da for single-charge ions, or within the mass accuracy specification for the instrument) confirms that the dominant compound has the correct molecular mass for the declared peptide.
Interpreting LC-MS Identity Data
A valid LC-MS identity result on a COA should state the theoretical molecular weight of the declared compound and the observed molecular weight of the detected compound. It may also show the deconvoluted mass spectrum or list the m/z values for the dominant charge states.
A mass mismatch — where the observed mass does not correspond to the declared compound's theoretical mass — is definitive evidence that the substance is not what it claims to be. This is the signature of substitution fraud and cannot be detected by HPLC alone.
Limitations of LC-MS
- LC-MS confirms that a compound with the correct mass is present — it does not confirm the correct amino acid sequence or stereochemistry (D-amino acid substitutions have identical mass to L-amino acid equivalents)
- More advanced MS/MS (tandem mass spectrometry) sequence analysis can address stereochemistry and sequence confirmation but is not standard on commercial COAs
- Like HPLC, LC-MS does not test for biological contaminants
Why Both Methods Are Necessary
HPLC and LC-MS are complementary, not interchangeable. A COA with only HPLC data confirms purity but not identity — you know the sample is predominantly one compound, but not which compound. A COA with only LC-MS data confirms that the correct compound is present, but does not tell you its relative purity against the full sample matrix.
Only the combination of both methods provides the minimum meaningful evidence that a research peptide contains the declared compound at research-grade purity. Any COA lacking either method should be treated as incomplete verification.
Independence: Why the Laboratory Matters
Even technically correct HPLC and LC-MS results are worthless if produced by a laboratory that is not independent of the vendor. An in-house laboratory operates under the same commercial incentives as the vendor and without external accountability. The analysis may be technically competent and the results accurate — but without independence, there is no mechanism to detect the cases where they are not.
A genuinely independent laboratory is a separately registered business entity that performs analysis for multiple clients and whose results are not subject to vendor approval before issuance. ISO 17025 accreditation, while not mandatory, is the recognised international standard for laboratory competence and impartiality — its presence on a COA is a meaningful positive signal.